You are here

Clinical Trials: Cord Blood

Condition:   Pulmonary Hypertension
Interventions:   Biological: adipose derived mesenchymal stem cells;   Drug: Conventional drug therapy(expectorant,bronchodilator)
Sponsor:   Liaocheng People's Hospital
Recruiting
Condition:   Irreversible Pulpitis
Interventions:   Other: Cord blood stem cells;   Other: Saline solution
Sponsor:   University of California, San Francisco
Not yet recruiting
Condition:   Knee Osteoarthritis
Interventions:   Biological: SMUP-IA-01(low-dose);   Biological: SMUP-IA-01(mid-dose);   Biological: SMUP-IA-01(high-dose)
Sponsor:   Medipost Co Ltd.
Not yet recruiting
Condition:   Viral Infection
Intervention:   Biological: HLA-matched VSTs
Sponsors:   Baylor College of Medicine;   The Methodist Hospital System;   Texas Children's Hospital
Not yet recruiting
Conditions:   Stroke;   Umbilical Cord Blood;   Erythropoietin;   Safety;   Treatment Outcome
Interventions:   Drug: Umbilical cord blood infusion;   Drug: Erythropoietin injection;   Drug: Placebo umbilical cord blood infusion;   Drug: Placebo erythropoietin injection;   Procedure: Active rehabilitation
Sponsors:   Bundang CHA Hospital;   Korea Evaluation Institute of Industrial Technology
Recruiting
Conditions:   Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis
Intervention:   Combination Product: Stem Cell Educator therapy combined with minoxidil
Sponsors:   Tianhe Stem Cell Biotechnologies Inc.;   Yale University;   Hackensack Meridian Health
Not yet recruiting
Condition:   Type 1 Diabetes
Intervention:   Combination Product: Stem Cell Educator therapy
Sponsors:   Tianhe Stem Cell Biotechnologies Inc.;   Hackensack Meridian Health
Not yet recruiting
Condition:   Bronchopulmonary Dysplasia
Interventions:   Biological: PNEUMOSTEM®;   Biological: normal saline
Sponsor:   Medipost Co Ltd.
Not yet recruiting
Condition:   Spinal Cord Injuries
Interventions:   Biological: Umbilical Cord Blood Mononuclear Cell;   Drug: Lithium Carbonate;   Other: Placebo;   Other: Locomotor Training
Sponsors:   StemCyte, Inc.;   Amarex Clinical Research
Not yet recruiting
Condition:   Acute Myeloid Leukemia
Intervention:   Biological: Unrelated cord blood
Sponsors:   Ruijin Hospital;   Navy General Hospital of PLA;   Beijing Jishuitan Hospital;   The Affiliated Hospital of Xuzhou Medical University;   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University;   Luoyang Central Hospital;   People's Hospital of Zhengzhou University;   Dongguan People's Hospital;   The First Affiliated Hospital of Xiamen University;   Taian City Central Hospital;   Qilu Hospital of Shandong University (Qingdao)
Recruiting

Pages